February, 2018 - CanadaCGM.com

2018 Clinical Practice Guidelines / Monitoring Glycemic Control / Diabetes Canada Clinical Practice Guidelines Expert Committee

Clinical Practice Guidelines: Monitoring Glycemic Control – Canadian Journal of Diabetes – 2018🍁

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycemia – Diabetic Medicine – 2018

The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study – Canadian Journal of Diabetes

The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study – Canadian Journal of Diabetes – 2018

Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada

Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada – BMJ Open Diabetes Research & Care – 2018🍁

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study – Journal of Clinical Endocrinology & Metabolism – 2018

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program – Diabetes Technology & Therapeutics – 2018

This site is intended for heath plan professionals in Canada.

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM

Watch Now

2018 Clinical Practice Guidelines / Monitoring Glycemic Control / Diabetes Canada Clinical Practice Guidelines Expert Committee

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study – Canadian Journal of Diabetes

Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Footer Content

Provided by

This site is intended for heath plan professionals in Canada.

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence: CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM System Approved by Health Canada

ADA 2023 Highlights: The Clinical and Economic Value of CGMWatch Now

2018 Clinical Practice Guidelines / Monitoring Glycemic Control / Diabetes Canada Clinical Practice Guidelines Expert Committee

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study – Canadian Journal of Diabetes

Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Footer Content

Provided by

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM

Watch Now